ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,000 | +74.5% | 2,819 | +61.2% | 0.00% | – |
| Q2 2023 | $94,000 | +161.1% | 1,749 | +93.3% | 0.00% | – |
| Q1 2023 | $36,000 | -57.1% | 905 | -56.9% | 0.00% | – |
| Q4 2022 | $84,000 | +663.6% | 2,098 | +506.4% | 0.00% | – |
| Q3 2022 | $11,000 | +37.5% | 346 | +31.6% | 0.00% | – |
| Q2 2022 | $8,000 | -66.7% | 263 | -69.6% | 0.00% | – |
| Q1 2022 | $24,000 | -76.0% | 864 | -60.1% | 0.00% | – |
| Q4 2021 | $100,000 | +185.7% | 2,164 | +101.9% | 0.00% | – |
| Q3 2021 | $35,000 | +16.7% | 1,072 | +24.4% | 0.00% | – |
| Q2 2021 | $30,000 | +50.0% | 862 | +53.4% | 0.00% | – |
| Q1 2021 | $20,000 | -82.0% | 562 | -85.3% | 0.00% | – |
| Q4 2020 | $111,000 | +2.8% | 3,817 | -0.2% | 0.00% | – |
| Q3 2020 | $108,000 | -10.7% | 3,823 | +1.8% | 0.00% | – |
| Q2 2020 | $121,000 | -20.4% | 3,755 | +0.8% | 0.00% | – |
| Q1 2020 | $152,000 | -11.1% | 3,726 | +34.0% | 0.00% | – |
| Q4 2019 | $171,000 | -12.8% | 2,781 | +3.2% | 0.00% | – |
| Q3 2019 | $196,000 | -13.7% | 2,696 | -2.5% | 0.00% | – |
| Q2 2019 | $227,000 | +233.8% | 2,765 | +186.8% | 0.00% | – |
| Q1 2019 | $68,000 | +70.0% | 964 | +8.2% | 0.00% | – |
| Q4 2018 | $40,000 | -43.7% | 891 | -28.8% | 0.00% | – |
| Q3 2018 | $71,000 | +195.8% | 1,251 | +253.4% | 0.00% | – |
| Q2 2018 | $24,000 | +500.0% | 354 | +436.4% | 0.00% | – |
| Q1 2018 | $4,000 | -50.0% | 66 | -45.9% | 0.00% | – |
| Q4 2017 | $8,000 | -76.5% | 122 | -81.1% | 0.00% | – |
| Q3 2017 | $34,000 | +580.0% | 644 | +631.8% | 0.00% | – |
| Q2 2017 | $5,000 | -50.0% | 88 | -58.7% | 0.00% | – |
| Q1 2017 | $10,000 | -80.0% | 213 | -74.2% | 0.00% | – |
| Q4 2016 | $50,000 | +11.1% | 826 | +21.3% | 0.00% | – |
| Q3 2016 | $45,000 | +275.0% | 681 | +208.1% | 0.00% | – |
| Q2 2016 | $12,000 | +71.4% | 221 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -53.3% | 221 | -35.0% | 0.00% | – |
| Q4 2015 | $15,000 | -81.7% | 340 | -83.6% | 0.00% | – |
| Q3 2015 | $82,000 | +485.7% | 2,078 | +840.3% | 0.00% | – |
| Q2 2015 | $14,000 | 0.0% | 221 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | -51.7% | 221 | -57.6% | 0.00% | – |
| Q4 2014 | $29,000 | +480.0% | 521 | +168.6% | 0.00% | – |
| Q3 2014 | $5,000 | -87.8% | 194 | -83.8% | 0.00% | – |
| Q2 2014 | $41,000 | +583.3% | 1,194 | +512.3% | 0.00% | – |
| Q1 2014 | $6,000 | +100.0% | 195 | +14.7% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 170 | +1.8% | 0.00% | – |
| Q3 2013 | $2,000 | – | 167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |